Valeant Pharmaceuticals International (VRX) · page 13 of 39
The slide uses a list format to build a case for regulatory scrutiny.
Activist deck · expose_contradiction · expose_contradiction · balanced density
Slide locked Sign in to view
Slide schematic 6/6
callout 1/1 list 4/4 title 1/1
Components 6
primary bullet bullet bullet bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1